Carl PetersenCarl Petersen studied physics as a bachelor student in Oxford (1989-1992). During his PhD studies under the supervision of Prof. Sir Michael Berridge in Cambridge (1992-1996), he investigated cellular and molecular mechanisms of calcium signalling. In his first postdoctoral period (1996-1998), he joined the laboratory of Prof. Roger Nicoll at the University of California San Francisco (UCSF) to investigate synaptic transmission and plasticity in the hippocampus. During a second postdoctoral period, in the laboratory of Prof. Bert Sakmann at the Max Planck Institute for Medical Research in Heidelberg (1999-2003), he began working on the primary somatosensory barrel cortex, investigating cortical circuits and sensory processing. Carl Petersen joined the Brain Mind Institute of the Faculty of Life Sciences at the Ecole Polytechnique Federale de Lausanne (EPFL) in 2003, setting up the Laboratory of Sensory Processing to investigate the functional operation of neuronal circuits in awake mice during quantified behavior. In 2019, Carl Petersen became the Director of the EPFL Brain Mind Institute, with the goal to promote quantitative multidisciplinary research into neural structure, function, dysfunction, computation and therapy through technological advances.
Felix SchürmannFelix Schürmann is co-director of the Blue Brain Project and involved in several research challenges of the European Human Brain Project. He studied physics at the University of Heidelberg, Germany, supported by the German National Academic Foundation. Later, as a Fulbright Scholar, he obtained his Master's degree (M.S.) in Physics from the State University of New York, Buffalo, USA, under the supervision of Richard Gonsalves. During these studies, he became curious about the role of different computing substrates and dedicated his master thesis to the simulation of quantum computing. He studied for his Ph.D. at the University of Heidelberg, Germany, under the supervision of Karlheinz Meier. For his thesis he co-designed an efficient implementation of a neural network in hardware.
Hilal Lashuel2012-2013 Visiting Professor, Standford University. Stanford School of Medicine
2011- Associate Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Chemical Biology of Neurodegeneration
2005-2011 Assistant Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Molecular Neurobiology and Neuroproteomics
2005-2008 Director- EPFL Proteomic Core Facility
2002-2004 Instructor of Neurology- Harvard Medical School and Brigham and Women's
Hospital
2001-2002 Sabbatical Fellow- Laboratory for Drug Discovery in Neurodegeneration
Harvard Medical School,
2001-2002 Post-doctoral Fellow- Center for Neurologic Diseases
Harvard Medical School and Brigham and Women's Hospital
Advisor- Prof. Peter T. Lansbury
2000-2001 Research Scientist, The Picower Institute for Medical Research, Great Neck
New York
1994-2000 PhD Student; Texas A&M University and the Scripps Research Institute
Advisor- Prof. Jeffery W. Kelly
1990-1994 B.S. City University of New York, Brooklyn College
Dr. Hilal A. Lashuel received his B.Sc. degree in chemistry from the City University of New York in 1994 and completed his doctoral studies at Texas A&M University and the Scripps Research Institute in 2000. After obtaining his doctoral degree, he became a research fellow at the Picower Institute for Medical Research in Long Island New York. In 2001, he moved to Harvard Medical School and the Brigham and Women's Hospital as a research fellow in the Center for Neurologic Diseases and was later promoted to an instructor in neurology at Harvard Medical School. During his tenure (2001-2004) at Harvard Medical School his work focused on understanding the mechanisms of protein misfolding and fibrillogenesis and the role of these processes in the pathogenesis of Parkinson's and Alzheimer's disease. In 2005 Dr. Lashuel moved Switzerland to join the Brain Mind Institute at the Swiss Federal Institute of Technology Lausanne as a tenure-track assistant professor in neurosciences. Currently, Dr. Lashuel is an associate professor of life sciences and the director of the laboratory of molecular and chemical biology of neurodegeneration. (http://lashuel-lab.epfl.ch/).
Research efforts in the Lashuels laboratory focus on understanding the molecular mechanisms of neurodegeneration and developing novel strategies to diagnose and treat neurodegenerative diseases such as Alzheimers and Parkinsons disease. Research in the Lashuel lab is funded by several international funding agencies and foundations, including the Swiss National Science Foundation, European FP7 program (Marie Curie and ERC grants), Human Science Frontiers, Strauss Foundation, Cure the Huntingtons disease foundation and Michael J Fox foundation and is supported by collaborations with pharmaceutical and biotech companies (http://lashuel-lab.epfl.ch/page-50538-en.html), Nestle, Merck-Serono, AC Immune and Johnson and Johnson.
Dr. Lashuels research has resulted in the characterization of novel quaternary structure intermediates on the amyloid pathway, identification of potential therapeutic targets, and new hypotheses concerning the mechanisms of pathogenesis in Alzheimers disease, Parkinsons disease and related disorders. Dr. Lashuel scientific contribution to this field includes i) more than100 publications in major peer reviewed journals including Nature journals, Cell, PNAS, JBC, J. Neuroscience JACS, and Angewandtie Chemie; ii) three patents on novel strategies for preventing protein aggregation and treating autoimmune and inflammatory diseases; iii) more than 150 invited lectures since 2002 and more than 5500 citations (7800 citation-Google Scholar) since 1996. Dr. Lashuel has received several pre-doctoral and post-doctoral awards and fellowships and was the recipient of two prestigious awards given to young investigators; Human Science Frontiers young investigator research award and the European Research Council (ERC) starting independent researcher grant and the ERC proof of concept award (2013) These awards provide more than $2.5 Million to Dr. Lashuel to translate some of his ideas and projects into novel strategies for diagnosing and treating neurodegenerative diseases such as Alzheimers and Parkinsons disease. Dr. Lashuel has chaired and co-organized several international conferences and serves as an academic editor for PLoS ONE, an associate editor for frontiers of molecular neuroscience, member of the Editorial advisory board of ChemBioChem and ad hoc reviewer for several international scientific journals and funding agencies. Olaf BlankeTeaching & PhD PhD Students Haotian Yao, Neza Vehar, Gerardus Yannick Mijsters, Andreea-Maria Gui, Unnat Hemangbhai Antani, Angelica Di Domenico, Berenice Favre-Bulle Past EPFL PhD Students Manuel Mercier, Bigna Lenggenhager, Pär Halje, Tej Tadi, Sebastian Dieguez Falcon, Oliver Alan Kannape, Lukas Heydrich, Nathan Evans, Danilo Jimenez Rezende, Steven Gale, Christian Pfeiffer, Mariia Kaliuzhna, Joachim Forget, Polona Pozeg, Petr Grivaz, Michel Akselrod, Marco Solcà, Jemina Fasola, Eva Blondiaux, Myeong S
Ralf SchneggenburgerTeaching & PhD PhD Students Nishant Jana, Runzhong Zhang, Jinyun Wu, Elena Mombelli Past EPFL PhD Students Le Xiao, Yunyun Han, Özgür Genç, Elin Kronander, Enida Gjoni, Wei Tang, Ayah Khubieh, Aiste Baleisyte, Shriya Palchaudhuri, Denys Osypenko, Bei-Xuan Lin Courses Neural circuits of motivated behaviors BIO-499 Motivated behaviors fulfil the basic physiological needs of animals and enable their safety. In this course, you will learn about the neuronal circuits that sense and regulate int
Gabriele GrenninglohSince 2017:Deputy Director, Brain Mind Institute, EPFL-SV2010 - 2014: Co-Manager, NCCR Synapsy, EPFL2005 - 2017:Deputy Head of the Laboratory of Neuroenergetics and Cellular Dynamics, EPFL-SV-LNDC and Deputy Director, Brain Mind Institute, EPFL-SV1997 - 2005:Group Leader, then Assistant Professor at the University of Lausanne1992 - 1997Senior Scientist, Glaxo Institute for Molecular Biology, Plan-les-Ouates, CH1989 - 1991Postdoc, then Research Geneticist, University of California at Berkeley, USA
Alessandra GriffaCurrent work
In recent years developments in graph theoretical analysis have been more and more applied to the study and characterization of both functional and structural brain networks. The human connectome has been characterized as a small-world, modular, hierarchical network, with few central nodes acting as connectors between local communities, and highly interconnected between them. This brain characterization is common to both structural and functional connectivity. Nevertheless the correlation betwe
